AU1536999A - Modified sv40 viral vectors - Google Patents

Modified sv40 viral vectors

Info

Publication number
AU1536999A
AU1536999A AU15369/99A AU1536999A AU1536999A AU 1536999 A AU1536999 A AU 1536999A AU 15369/99 A AU15369/99 A AU 15369/99A AU 1536999 A AU1536999 A AU 1536999A AU 1536999 A AU1536999 A AU 1536999A
Authority
AU
Australia
Prior art keywords
modified
viral vectors
viral
vectors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU15369/99A
Inventor
Kevin S. Casement
Bingliang Fang
Steven L. HIGHLANDER
Jack A Roth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Texas System
Original Assignee
University of Texas System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Texas System filed Critical University of Texas System
Publication of AU1536999A publication Critical patent/AU1536999A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/22011—Polyomaviridae, e.g. polyoma, SV40, JC
    • C12N2710/22041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/22043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU15369/99A 1997-11-26 1998-11-25 Modified sv40 viral vectors Abandoned AU1536999A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US97853997A 1997-11-26 1997-11-26
US08978539 1997-11-26
PCT/US1998/025225 WO1999027123A2 (en) 1997-11-26 1998-11-25 Modified sv40 viral vectors

Publications (1)

Publication Number Publication Date
AU1536999A true AU1536999A (en) 1999-06-15

Family

ID=25526193

Family Applications (1)

Application Number Title Priority Date Filing Date
AU15369/99A Abandoned AU1536999A (en) 1997-11-26 1998-11-25 Modified sv40 viral vectors

Country Status (2)

Country Link
AU (1) AU1536999A (en)
WO (1) WO1999027123A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6656732B1 (en) 2001-05-18 2003-12-02 Isis Pharmaceuticals, Inc. Antisense inhibition of src-c expression
WO2007064971A2 (en) * 2005-12-01 2007-06-07 The Government Of The Usa, As Represented By The Secretary, Dept. Of Health & Human Services Infectious papovavirus particle comprising a cytocidal gene and methods of use thereof
GB2439543A (en) * 2006-06-27 2008-01-02 Viruvation B V Polyoma viral vector production cell lines and nucleic acids expressing dsRNA viral sequences
EP2243836A1 (en) * 2009-04-22 2010-10-27 Amarna Therapeutics B.V. Method for the production of recombinant polymavirus vector particles
WO2015118146A1 (en) 2014-02-10 2015-08-13 Univercells Nv System, apparatus and method for biomolecules production

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ225470A (en) * 1987-07-21 1990-06-26 Du Pont Stable and viable recombinant viral vectors
AU4649396A (en) * 1994-12-30 1996-07-24 Thomas Jefferson University Gene transduction system
IL122614A0 (en) * 1995-06-15 1998-08-16 Introgene Bv Packaging systems for human recombinant adenovirus to be used in gene therapy

Also Published As

Publication number Publication date
WO1999027123A2 (en) 1999-06-03
WO1999027123A9 (en) 1999-09-16
WO1999027123A3 (en) 1999-08-12

Similar Documents

Publication Publication Date Title
AU8828598A (en) Retrovirus and viral vectors
AU2678097A (en) Targeted viral vectors
AU5638496A (en) Viral vectors
GB9524973D0 (en) Viral vectors
AU1124499A (en) Human papillomavirus vectors
AU8443198A (en) Switch arrangement
AU3309997A (en) Recombinant adeno-associated viral vectors
AU3119895A (en) Recombinant virus vectors
EP0990271A4 (en) Loudspeaker assembly
AU9066598A (en) Substituted 4-benzoyl-pyrazoles
IL122349A0 (en) Adeno-associated viral vectors
AU4099699A (en) Improved vectors
AUPO026596A0 (en) Viral peptide
AU5652396A (en) Glucose-inducible recombinant viral vector
AU6525998A (en) Improved metallo-endopeptidases
AU1536999A (en) Modified sv40 viral vectors
AU8630598A (en) New herbicidal mixtures
AU6000698A (en) Proteins
AU6090898A (en) Substituted 4-benzoyl-pyrazoles
AU5765698A (en) Suspension loop arrangement
GB9704142D0 (en) Loudspeakers
AU8972598A (en) Loudspeaker arrangement
GB2334257B (en) Rectroviral vectors
GB2331752B (en) Vectors
AU8439398A (en) Substituted aryluracil herbicides

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase